再発危険因子を有するStageⅡ大腸癌に対するUFT/LV療法の臨床的有用性に関する研究（JFMC46-1201）の最終論文がInternational Journal of Clinical Oncologyに掲載されました。

 

Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity score-based methods (JFMC46-1201)

 

Yutaka Ogata, Sotaro Sadahiro, Kazuhiro Sakamoto, Takashi Tsuchiya, Takao Takahashi, Hiroki Ohge, Toshihiko Sato, Ken Kondo, Hideo Baba, Michio Itabashi, Masataka Ikeda, Madoka Hamada, Kiyoshi Maeda, Hiroyuki Masuko, Kiichi Takahashi, Mitsuo Kusano, Ichinosuke Hyodo, Junichi Sakamoto, Masataka Taguri, Satoshi Morita

 

 

International Journal of Clinical Oncology

DOI: 10.1007/s10147-024-02565-5

https://link.springer.com/article/10.1007/s10147-024-02565-5